FDA-Cleared Osteoboost Wearable Device Now Available to Help 60M+ Americans Combat Low Bone Density
Osteoboost Health Launches FDA-Cleared Prescription Wearable for Low Bone Density, Addressing Needs of Over 60 Million Americans Redwood City, Calif.--(Business Wire)--Osteoboost Health, Inc. has announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device designed for individuals with low bone density. This innovative wearable aims to bridge the gap between advanced consumer health technology and rigorously tested medical devices. Osteoboost is a sleek and user-friendly belt that delivers targeted vibration therapy to the spine and hips—areas most vulnerable to osteoporotic fractures. The device is designed for convenient, at-home use, requiring just 30 minutes of daily therapy that can be seamlessly integrated into everyday activities like walking or reading. According to Laura Yecies, CEO of Osteoboost Health, "Osteoboost empowers individuals to lead longer, stronger, and more active lives. Despite its sophisticated medical technology, the treatment is straightforward—30 minutes a day of vibration therapy, easily incorporated into your routine." A gold-standard, double-blinded, placebo-controlled clinical trial conducted at the University of Nebraska Medical Center demonstrated the efficacy of Osteoboost. Participants who were postmenopausal women with osteopenia and used the device at least three times per week experienced a significant slowdown in bone density and strength loss. Dr. Yevgeniya Kushchaeva, Clinical Director of University of South Florida Health Adult Endocrinology and Medical Director of the Adult Osteoporosis Program, emphasized the importance of Osteoboost's approach. "Innovation in bone health has been scarce, leaving many patients deeply concerned about their daily risks," she explained. "Osteoboost has taken a thorough and diligent path, investing years in clinical trials and securing FDA approval. This is no small feat, even for large pharmaceutical companies." The launch of Osteoboost has been bolstered by strategic investments from AARP, Harvard Business School Angels, and She's Independent, as well as a follow-on investment from Esplanade Healthtech Ventures. These partnerships underscore the device's potential to make a significant impact on public health. For more details, including comprehensive instructions for use, visit https://osteoboost.com. About Osteoboost Health, Inc. Osteoboost Health, Inc. is a medical technology company committed to developing non-invasive, scientifically validated solutions for individuals with low bone density. The company's focus is on creating devices that are both effective and easy to incorporate into daily life, helping users maintain and improve their bone health. Visit https://osteoboost.com for additional information.
